Economic Burden of Checkpoint Inhibitor Immunotherapy for...

  • Main
  • 2020 / 7
  • Economic Burden of Checkpoint Inhibitor Immunotherapy for...

Economic Burden of Checkpoint Inhibitor Immunotherapy for the Treatment of Non–Small Cell Lung Cancer in US Clinical Practice

Nesline, Mary K., Knight, Tyler, Colman, Sam, Patel, Kayshap
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Therapeutics
DOI:
10.1016/j.clinthera.2020.06.018
Date:
July, 2020
File:
PDF, 1.34 MB
2020
Conversion to is in progress
Conversion to is failed